<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_CUTHRE100602 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Ther Res Clin Exp</journal-id><journal-id journal-id-type="iso-abbrev">Curr Ther Res Clin Exp</journal-id><journal-title-group><journal-title>Current Therapeutic Research, Clinical and Experimental</journal-title></journal-title-group><issn pub-type="ppub">0011-393X</issn><issn pub-type="epub">1879-0313</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7445151</article-id><article-id pub-id-type="publisher-id">S0011-393X(20)30028-X</article-id><article-id pub-id-type="doi">10.1016/j.curtheres.2020.100602</article-id><article-id pub-id-type="publisher-id">100602</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title><italic>Nigella sativa</italic> L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0001"><name><surname>Koshak</surname><given-names>Dr Abdulrahman E.</given-names></name><email>aekoshak@kau.edu.sa</email><xref rid="aff0001" ref-type="aff">1</xref><xref rid="cor0001" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="au0002"><name><surname>Koshak</surname><given-names>Prof Emad A.</given-names></name><xref rid="aff0002" ref-type="aff">2</xref></contrib><aff id="aff0001"><label>1</label>Department of Natural Products &#x00026; Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia</aff><aff id="aff0002"><label>2</label>Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia</aff></contrib-group><author-notes><corresp id="cor0001"><label>&#x0204e;</label>Address correspondence to: Dr Abdulrahman E. Koshak, 80260 Department of Natural Products &#x00026; Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia. <email>aekoshak@kau.edu.sa</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>25</day><month>8</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>25</day><month>8</month><year>2020</year></pub-date><volume>93</volume><elocation-id>100602</elocation-id><history><date date-type="received"><day>10</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Author(s)</copyright-statement><copyright-year>2020</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0001"><sec><title>Background</title><p>Coronaviruses are responsible for several human diseases, such as the infectious novel coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). <italic>Nigella sativa</italic> is a natural food supplement with a known safety profile that may provide a wealth of documented antiviral compounds.</p></sec><sec><title>Objective</title><p>To explore the studies supporting the <italic>N sativa</italic> potential for hitting SARS-CoV-2 targets.</p></sec><sec><title>Methods</title><p>A literature search for published or preprint in silico studies between 1990 and 2020 in electronic databases (PubMed, Science Direct, Scopus, and Google Scholar) was performed for the terms Nigella sativa, <italic>black seed, coronavirus, SARS-CoV-2</italic>, and <italic>COVID-19</italic>.</p></sec><sec><title>Results</title><p>At least 8 in silico studies have shown that some compounds of <italic>N sativa</italic>, including nigelledine, &#x003b1;-hederin, hederagenin, thymohydroquinone, and thymoquinone, had high to moderate affinity with SARS-CoV-2 enzymes and proteins. These compounds may potentially inhibit SARS-CoV-2 replication and <italic>attachment to host cell receptors</italic>.</p></sec><sec><title>Conclusions</title><p>These preliminary data of in silico studies propose <italic>N sativa</italic> as a potential phytotherapy candidate for COVID-19. Further preclinical experimental evidence is required followed by a Phase I clinical trial. (<italic>Curr Ther Res Clin Exp</italic>. 2020; 81:XXX&#x02013;XXX)</p></sec></abstract><kwd-group id="keys0001"><title>Keywords</title><kwd>Coronavirus</kwd><kwd>COVID-19</kwd><kwd>in silico</kwd><kwd><italic>Nigella sativa</italic></kwd><kwd>SARS-CoV-2</kwd></kwd-group></article-meta></front><body><sec id="sec0001"><title>Introduction</title><p id="para0006">Coronaviruses, enveloped RNA viruses, are characterized by spikes on their surface and belong to <italic>Nidovirales</italic> order.<xref rid="bib0001" ref-type="bibr"><sup>1</sup></xref> They are responsible for a growing economic, social, and mortality burden in humans over the past decades. The spectrum of diseases associated with human coronaviruses range from the common cold to severe acute respiratory syndrome, and Middle East respiratory syndrome. Since December 2019, a newly discovered&#x000a0;severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been the causative agent of the current pandemic of infectious disease called coronavirus disease 2019 (COVID-19). Unfortunately, there are no effective approved antiviral agents for these coronavirus strains.<xref rid="bib0002" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="bib0003" ref-type="bibr"><sup>3</sup></xref></p><p id="para0007">Natural products provide a wealth of biologically active molecules with antiviral activity, and thus may have utility as potential therapeutic agents against coronavirus infections.<xref rid="bib0004" ref-type="bibr"><sup>4</sup></xref> Among these products is <italic>Nigella sativa</italic>, which has displayed several antiviral properties.<xref rid="bib0005" ref-type="bibr"><sup>5</sup></xref></p><p id="para0008"><italic>N sativa</italic> is a well-known food supplement and medicinal plant in different cultures. The seeds of <italic>N sativa</italic> contain several active compounds in the classes of fixed oil, essential oil, saponins, and alkaloids. In the literature, <italic>N sativa</italic> exhibited several pharmacological properties including anti-inflammatory, antimicrobial, and immunostimulatory activities.<xref rid="bib0005" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="bib0006" ref-type="bibr"><sup>6</sup></xref></p><p id="para0009">The safety and efficacy of <italic>N sativa</italic> used for many human diseases has been established in several randomized clinical studies.<xref rid="bib0007" ref-type="bibr"><sup>7</sup></xref> We also used <italic>N sativa</italic> oil in a randomized, double-blind placebo-controlled trial on asthmatic patients with acceptable safety and efficacy profile.<xref rid="bib0008" ref-type="bibr"><sup>8</sup></xref> Moreover, several meta-analyses have confirmed the beneficial effects and safety of <italic>N sativa</italic> on hyperlipidemia, type 2 diabetes, obesity, hypertension, and asthma.<xref rid="bib0009" ref-type="bibr">9</xref>, <xref rid="bib0010" ref-type="bibr">10</xref>, <xref rid="bib0011" ref-type="bibr">11</xref>, <xref rid="bib0012" ref-type="bibr">12</xref>, <xref rid="bib0013" ref-type="bibr">13</xref> In a clinical study, Oral <italic>N sativa</italic> oil dosing of up to 5 g daily for up to 12 weeks is believed to be safe.<xref rid="bib0014" ref-type="bibr"><sup>14</sup></xref></p><p id="para0010">In in vitro studies, the antiviral activities of <italic>N sativa</italic> on different viruses were documented in the literature.<xref rid="bib0005" ref-type="bibr"><sup>5</sup></xref>
<italic>N sativa</italic> oil suppresses the viral load of murine cytomegalovirus in infected mice to an undetectable level.<xref rid="bib0015" ref-type="bibr"><sup>15</sup></xref>
<italic>N sativa</italic> honey was found to inhibit HIV-1 replication.<xref rid="bib0016" ref-type="bibr"><sup>16</sup></xref>
<italic>N sativa</italic> had virucidal activity against herpes simplex and hepatitis A virus infections.<xref rid="bib0016" ref-type="bibr"><sup>16</sup></xref>
<italic>N sativa</italic> decreased the coronavirus load in infected HeLa cells with stimulated interleukin 8 secretion and downregulation of transient receptor potential (TRP) genes expression such as TRPM6, TRPA1, TRPC4, and TRPM7.<xref rid="bib0017" ref-type="bibr"><sup>17</sup></xref> Hepatitis C virus replication was inhibited by <italic>N sativa</italic>.<xref rid="bib0018" ref-type="bibr"><sup>18</sup></xref>
<italic>N sativa</italic> inhibited the growth of influenza virus H5N1 in vitro.<xref rid="bib0019" ref-type="bibr"><sup>19</sup></xref></p><p id="para0011">In a human clinical study, patients with hepatitis C virus infection showed significant improvement in hepatitis C virus viral load after 3 months of <italic>N sativa</italic> treatment.<xref rid="bib0020" ref-type="bibr"><sup>20</sup></xref> A case report of treatment with <italic>N sativa</italic> for 6 months showed a sustained seroreversion in a 46-year-old HIV patient and was also reported in an additional 6 HIV cases.<xref rid="bib0021" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib0022" ref-type="bibr"><sup>22</sup></xref></p><p id="para0012">In recent years, in silico molecular docking studies on natural products enable computational screening approaches for assessing their therapeutic potential. These studies utilize bioinformatics techniques and can be used to discover how candidate drugs cause therapeutic activity by predicting interactions between drugs and proteins, and analysis of influence on biological pathways and functions.<xref rid="bib0023" ref-type="bibr"><sup>23</sup></xref></p><p id="para0013">The aim of this mini literature review was to explore any publication or preprint on in silico studies of the specific anticoronavirus potential of <italic>N sativa</italic>.</p></sec><sec id="sec0002"><title>Methods</title><p id="para0014">A literature search for scientific published manuscripts or preprint in silico studies found in electronic databases (PubMed, Science Direct, Scopus, and Google Scholar) was performed using the terms Nigella sativa, <italic>black seed, coronavirus, SARS-CoV-2</italic>, and <italic>COVID-19</italic>. Studies were searched for electronically between the years 1990 and 2020.</p></sec><sec id="sec0003"><title>Results</title><p id="para0015">In the literature review, there were at least 8 in silico studies that explored the effects of <italic>N sativa</italic> compounds on SARS-CoV-2. A summary of those studies is presented in the <xref rid="tbl0001" ref-type="table">Table 1</xref>. However, there have been no reported clinical trials on <italic>N sativa</italic> in human coronavirus cases at this time.<table-wrap position="float" id="tbl0001"><label>Table 1</label><caption><p>A summary of effects of <italic>Nigella sativa</italic> compounds on severe acute respiratory syndrome-coronavirus disease 2 (SARS-CoV-2) targets.</p></caption><alt-text id="alt0001">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reference</th><th valign="top"><italic>N sativa</italic> material</th><th valign="top">SARS-CoV-2 targets</th><th valign="top">Control</th><th valign="top">Effects</th></tr></thead><tbody><tr><td valign="top"><xref rid="bib0016" ref-type="bibr"><sup>16</sup></xref></td><td valign="top">Thymoquinone</td><td valign="top">6LU7</td><td valign="top">NA</td><td valign="top">-Thymoquinone had a moderate binding affinity with 6LU7</td></tr><tr><td valign="top"><xref rid="bib0017" ref-type="bibr"><sup>17</sup></xref></td><td valign="top">Nigellidine, &#x003b1;-Hederin</td><td valign="top">6LU7, 2GTB</td><td valign="top">-Chloroquine</td><td valign="top">-Nigellidine and &#x003b1;-hederin had the most binding affinity with 6LU7 and 2GTB</td></tr><tr><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top">-HCQ</td><td valign="top">-Nigelledine was better than HCQ and favipiravir</td></tr><tr><td valign="top"/><td valign="top"/><td valign="top"/><td valign="top">-Favipiravir</td><td valign="top">-&#x003b1;-Hederin better than chloroquine, HCQ, and favipiravir</td></tr><tr><td valign="top"><xref rid="bib0018" ref-type="bibr"><sup>18</sup></xref></td><td valign="top">Hederagenin</td><td valign="top">6LU7, 6Y2E</td><td valign="top">Saquinavir</td><td valign="top">-Hederagenin had a high binding affinity with 6LU7 but less than saquinavir and 6Y2E close to saquinavir</td></tr><tr><td valign="top"><xref rid="bib0019" ref-type="bibr"><sup>19</sup></xref></td><td valign="top">Nigellidine</td><td valign="top">6LU7, NSP2, 6vsb, QHD43415_3, QHD43423, IL1R, TNFR1, TNFR2</td><td valign="top">NA</td><td valign="top">-Nigellidine had a high binding affinity with several SARS-CoV-2 and inflammatory molecular targets</td></tr><tr><td valign="top"><xref rid="bib0020" ref-type="bibr"><sup>20</sup></xref></td><td valign="top">Hederagenin</td><td valign="top">ACE2, GRP78</td><td valign="top">NA</td><td valign="top">-Hederagenin had the highest binding affinity with ACE2 and GRP78</td></tr><tr><td valign="top"><xref rid="bib0021" ref-type="bibr"><sup>21</sup></xref></td><td valign="top">Thymoquinone</td><td valign="top">6LU7, ACE2</td><td valign="top">HCQ</td><td valign="top">-Thymoquinone had a moderate binding affinity with 6LU7 and ACE2 1R42, but less than HCQ</td></tr><tr><td valign="top"><xref rid="bib0022" ref-type="bibr"><sup>22</sup></xref></td><td valign="top">Thymoquinone</td><td valign="top">HSPA5</td><td valign="top">NA</td><td valign="top">-Thymoquinone had a moderate binding affinity to HSPA5</td></tr><tr><td valign="top"><xref rid="bib0023" ref-type="bibr"><sup>23</sup></xref></td><td valign="top">Thymohydro-quinone</td><td valign="top">6LU7, Nsp15 / NendoU, ADRP, RdRp, rS, ACE2</td><td valign="top">NA</td><td valign="top">-Thymohydroquinone had a moderate binding affinity with several SARS-CoV-2 molecular targets</td></tr></tbody></table><table-wrap-foot><fn><p>2GTB&#x0202f;=&#x0202f;main peptidase; 6LU7&#x0202f;=&#x0202f;main protease; 6vsb&#x0202f;=&#x0202f;spike glycoprotein; ACE2&#x0202f;=&#x0202f;angiotensin converting enzyme 2; ADRP&#x0202f;=&#x0202f;ADP-ribose-1&#x02033;-phosphatase; HCQ&#x0202f;=&#x0202f;hydroxychloroquine; HSPA5&#x0202f;=&#x0202f;heat shock protein A5; IL1R&#x0202f;=&#x0202f;interleukin 1 receptor; NA&#x0202f;=&#x0202f;not available. NSP2&#x0202f;=&#x0202f;nonstructural protein 2; Nsp15/NendoU&#x0202f;=&#x0202f;endoribonucleoase; QHD43415_3&#x0202f;=&#x0202f;N- terminus-protenase; QHD43423&#x0202f;=&#x0202f;nucleocapsid; RdRp&#x0202f;=&#x0202f;RNA-dependent RNA polymerase; rS&#x0202f;=&#x0202f;binding domain of SARS-CoV-2 spike protein; TNFR1&#x0202f;=&#x0202f;tumor necrosis factor receptor 1; TNFR2&#x0202f;=&#x0202f;tumor necrosis factor receptor 2.</p></fn></table-wrap-foot></table-wrap></p><p id="para0016">Molecular docking of compounds from <italic>N sativa</italic> and some antiviral drugs was performed to determine their binding affinity with SARS-CoV-2&#x02013;related molecular targets such as main proteases (6LU7 and 6Y2E), main peptidase (2GTB), angiotensin converting enzyme 2 (ACE2), and heat shock protein A5. The binding of some natural compounds might prevent the adhesion of coronavirus to host epithelial cells. Nigelledine, an alkaloid in <italic>N sativa</italic>, docked with 6LU7 active sites showed an energy complex score close to chloroquine and better than hydroxychloroquine and favipiravir. &#x003b1;-Hederin, a saponin in <italic>N sativa</italic>, docked with 2GTB active sites showed an energy score better than chloroquine, hydroxychloroquine, and favipiravir.<xref rid="bib0024" ref-type="bibr"><sup>24</sup></xref></p><p id="para0017">Thymoquinone, the main essential oil constituent of <italic>N sativa</italic>, had a binding affinity with 6LU7, ACE2, and heat shock protein A5 active sites with a score less than hydroxychloroquine in 6LU7 and ACE2.<xref rid="bib0025" ref-type="bibr"><sup>25</sup></xref><sup>,</sup><xref rid="bib0026" ref-type="bibr"><sup>26</sup></xref> Also, hederagenin, a saponin in <italic>N sativa</italic>, docked with 6LU7, 6Y2E, ACE2, and GRP78 active sites showed a binding score less than saquinavir in 6LU7 and 6Y2E.<xref rid="bib0027" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="bib0028" ref-type="bibr"><sup>28</sup></xref> Thymohydroquinone showed moderate docking energy with SARS-CoV-2 6LU7, endoribonucleoase, ADP-ribose-1&#x02033;&#x02212;phosphatase, RNA-dependent RNA polymerase, the binding domain of the SARS-CoV-2 spike protein, and human ACE2.<xref rid="bib0029" ref-type="bibr"><sup>29</sup></xref> Nigellidine showed high binding affinity SARS-CoV-2 enzymes and proteins such as N- terminus-protenase, 6LU7, nonstructural protein 2, spike-glycoprotein, and nucleocapsid. Nigellidine had high binding energy with human receptors, inflammatory signal molecules, and other proteins such as human IL1R (1itb), TNFR1 (1ncf), and TNFR2 (3alq).<xref rid="bib0030" ref-type="bibr"><sup>30</sup></xref></p><p id="para0018">Therefore, certain natural compounds found in <italic>N sativa</italic> such as nigellidine, &#x003b1;-hederin, hederagenin, thymohydroquinone, and thymoquinone were potentially active compounds that might inhibit coronavirus. Preclinical evidence is required to determine the activity of <italic>N sativa</italic> against coronavirus. If proven activity resulted from preclinical investigations, a clinical Phase I trial of <italic>N sativa</italic> in patients with COVID-19 is suggested to explore its clinical activity.</p></sec><sec id="sec0004"><title>Conclusions</title><p id="para0019">This mini literature review documented the inhibitory effects of some <italic>N sativa</italic> compounds against SARS-CoV-2 in several molecular docking studies. However, there is no reported clinical trial of <italic>N sativa</italic> in human coronavirus cases. Therefore, we propose <italic>N sativa</italic> as a potential phytotherapy candidate in further preclinical and clinical investigations in the treatment of coronavirus diseases such as COVID-19. Also, further in silico investigation on other natural products from traditional medicines is suggested to apply them in the treatment of COVID-19.</p></sec></body><back><ref-list id="cebibl1"><title>References</title><ref id="bib0001"><label>1</label><element-citation publication-type="book" id="sbref0001"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>AR</given-names></name><name><surname>Perlman</surname><given-names>S</given-names></name></person-group><chapter-title>Coronaviruses: An overview of their replication and pathogenesis</chapter-title><series>Coronaviruses: Methods and Protocols</series><volume>1282</volume><year>2015</year><publisher-name>Springer</publisher-name><publisher-loc>New York</publisher-loc><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-2438-7_1</pub-id></element-citation></ref><ref id="bib0002"><label>2</label><element-citation publication-type="book" id="sbref0002"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><chapter-title>Coronavirus</chapter-title><year>2020</year><comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/health-topics/coronavirus#tab=tab_1" id="interref0001">https://www.who.int/health-topics/coronavirus#tab=tab_1</ext-link> Published 2020. Accessed May 12</comment></element-citation></ref><ref id="bib0003"><label>3</label><element-citation publication-type="journal" id="sbref0003"><person-group person-group-type="author"><name><surname>Shereen</surname><given-names>MA</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Kazmi</surname><given-names>A</given-names></name><name><surname>Bashir</surname><given-names>N</given-names></name><name><surname>Siddique</surname><given-names>R</given-names></name></person-group><article-title>COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses</article-title><source>J Adv Res</source><volume>24</volume><year>2020</year><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jare.2020.03.005</pub-id><pub-id pub-id-type="pmid">32257431</pub-id></element-citation></ref><ref id="bib0004"><label>4</label><element-citation publication-type="journal" id="sbref0004"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>LT</given-names></name><name><surname>Hsu</surname><given-names>WC</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><article-title>Antiviral natural products and herbal medicines</article-title><source>J Tradit Complement Med</source><volume>4</volume><issue>1</issue><year>2014</year><fpage>24</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.4103/2225-4110.124335</pub-id><pub-id pub-id-type="pmid">24872930</pub-id></element-citation></ref><ref id="bib0005"><label>5</label><element-citation publication-type="book" id="sbref0005"><person-group person-group-type="author"><name><surname>Molla</surname><given-names>S</given-names></name><name><surname>Abul</surname><given-names>M</given-names></name><name><surname>Azad</surname><given-names>K</given-names></name></person-group><series>A REVIEW ON ANTIVIRAL EFFECTS OF <italic>NIGELLA SATIVA L. pharmacologyonline</italic></series><volume>2</volume><year>2019</year><fpage>47</fpage><lpage>53</lpage><ext-link ext-link-type="uri" xlink:href="http://pharmacologyonline.silae.it" id="interref0002">http://pharmacologyonline.silae.it</ext-link><comment>Accessed March 18, 2020.</comment></element-citation></ref><ref id="bib0006"><label>6</label><element-citation publication-type="journal" id="sbref0006"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>A</given-names></name><name><surname>Husain</surname><given-names>A</given-names></name><name><surname>Mujeeb</surname><given-names>M</given-names></name></person-group><article-title>A review on therapeutic potential of <italic>Nigella sativa</italic>: A miracle herb</article-title><source>Asian Pac J Trop Biomed</source><volume>3</volume><issue>5</issue><year>2013</year><fpage>337</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(13)60075-1</pub-id><pub-id pub-id-type="pmid">23646296</pub-id></element-citation></ref><ref id="bib0007"><label>7</label><element-citation publication-type="journal" id="sbref0007"><person-group person-group-type="author"><name><surname>Tavakkoli</surname><given-names>A</given-names></name><name><surname>Mahdian</surname><given-names>V</given-names></name><name><surname>Razavi</surname><given-names>BM</given-names></name><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name></person-group><article-title>Review on clinical trials of black seed (<italic>Nigella sativa</italic>) and its active constituent, thymoquinone</article-title><source>J Pharmacopuncture</source><volume>20</volume><issue>3</issue><year>2017</year><fpage>179</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.3831/KPI.2017.20.021</pub-id><pub-id pub-id-type="pmid">30087794</pub-id></element-citation></ref><ref id="bib0008"><label>8</label><element-citation publication-type="journal" id="sbref0008"><person-group person-group-type="author"><name><surname>Koshak</surname><given-names>A</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Koshak</surname><given-names>E</given-names></name></person-group><article-title><italic>Nigella sativa</italic> Supplementation Improves Asthma Control and Biomarkers: A Randomized, Double-Blind, Placebo-Controlled Trial</article-title><source>Phyther Res</source><volume>31</volume><issue>3</issue><year>2017</year><pub-id pub-id-type="doi">10.1002/ptr.5761</pub-id></element-citation></ref><ref id="bib0009"><label>9</label><element-citation publication-type="journal" id="sbref0009"><person-group person-group-type="author"><name><surname>He</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name></person-group><article-title>The influency of <italic>Nigella sativa</italic> for asthma control: A meta-analysis</article-title><source>Am J Emerg Med</source><year>November 2019</year><pub-id pub-id-type="doi">10.1016/j.ajem.2019.11.036</pub-id></element-citation></ref><ref id="bib0010"><label>10</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Sahebkar</surname><given-names>A</given-names></name><name><surname>Soranna</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name></person-group><article-title>A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with <italic>Nigella sativa</italic> (black seed) on blood pressure</article-title><source>J Hypertens</source><volume>34</volume><issue>11</issue><year>2016</year><fpage>2127</fpage><lpage>2135</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000001049</pub-id><pub-id pub-id-type="pmid">27512971</pub-id></element-citation></ref><ref id="bib0011"><label>11</label><element-citation publication-type="journal" id="sbref0011"><person-group person-group-type="author"><name><surname>Namazi</surname><given-names>N</given-names></name><name><surname>Larijani</surname><given-names>B</given-names></name><name><surname>Ayati</surname><given-names>MH</given-names></name><name><surname>Abdollahi</surname><given-names>M</given-names></name></person-group><article-title>The effects of <italic>Nigella sativa L</italic>. on obesity: A systematic review and meta-analysis</article-title><source>J Ethnopharmacol</source><volume>219</volume><year>2018</year><fpage>173</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.03.001</pub-id><pub-id pub-id-type="pmid">29559374</pub-id></element-citation></ref><ref id="bib0012"><label>12</label><element-citation publication-type="journal" id="sbref0012"><person-group person-group-type="author"><name><surname>Daryabeygi-Khotbehsara</surname><given-names>R</given-names></name><name><surname>Golzarand</surname><given-names>M</given-names></name><name><surname>Ghaffari</surname><given-names>MP</given-names></name><name><surname>Djafarian</surname><given-names>K</given-names></name></person-group><article-title><italic>Nigella sativa</italic> improves glucose homeostasis and serum lipids in type 2 diabetes: A systematic review and meta-analysis</article-title><source>Complement Ther Med</source><volume>35</volume><year>2017</year><fpage>6</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.ctim.2017.08.016</pub-id><pub-id pub-id-type="pmid">29154069</pub-id></element-citation></ref><ref id="bib0013"><label>13</label><element-citation publication-type="journal" id="sbref0013"><person-group person-group-type="author"><name><surname>Sahebkar</surname><given-names>A</given-names></name><name><surname>Beccuti</surname><given-names>G</given-names></name><name><surname>Simental-Mend&#x000ed;a</surname><given-names>LE</given-names></name><name><surname>Nobili</surname><given-names>V</given-names></name><name><surname>Bo</surname><given-names>S</given-names></name></person-group><article-title><italic>Nigella sativa</italic> (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials</article-title><source>Pharmacol Res</source><volume>106</volume><year>2016</year><fpage>37</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2016.02.008</pub-id><pub-id pub-id-type="pmid">26875640</pub-id></element-citation></ref><ref id="bib0014"><label>14</label><mixed-citation publication-type="other" id="sbref0014">Therapeutic Research Center. the Natural Medicines Research Collaboration. <ext-link ext-link-type="uri" xlink:href="https://naturalmedicines.therapeuticresearch.com/" id="interref0003">https://naturalmedicines.therapeuticresearch.com/</ext-link>. Published 2020. Accessed April 14, 2020.</mixed-citation></ref><ref id="bib0015"><label>15</label><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>ML</given-names></name><name><surname>Hossain</surname><given-names>MS.</given-names></name></person-group><article-title>Protective effect of black seed oil from <italic>Nigella sativa</italic> against murine cytomegalovirus infection</article-title><source>Int J Immunopharmacol</source><volume>22</volume><issue>9</issue><year>2000</year><fpage>729</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1016/S0192-0561(00)00036-9</pub-id><pub-id pub-id-type="pmid">10884593</pub-id></element-citation></ref><ref id="bib0016"><label>16</label><element-citation publication-type="journal" id="sbref0016"><person-group person-group-type="author"><name><surname>Barakat</surname><given-names>AB</given-names></name><name><surname>Shoman</surname><given-names>SA</given-names></name><name><surname>Dina</surname><given-names>N</given-names></name><name><surname>Alfarouk</surname><given-names>OR</given-names></name></person-group><article-title>Antiviral activity and mode of action of <italic>Dianthus caryophyllus L</italic>. and <italic>Lupinus termes L</italic>. seed extracts against in vitro herpes simplex and hepatitis A viruses infection</article-title><source>J Microbiol Antimicrob</source><volume>2</volume><issue>3</issue><year>2010</year><fpage>23</fpage><lpage>29</lpage><ext-link ext-link-type="uri" xlink:href="http://www.academicjournals.org/JMA" id="interref0004">http://www.academicjournals.org/JMA</ext-link><comment>Accessed April 24, 2020</comment></element-citation></ref><ref id="bib0017"><label>17</label><element-citation publication-type="journal" id="sbref0017"><person-group person-group-type="author"><name><surname>Ulasli</surname><given-names>M</given-names></name><name><surname>Gurses</surname><given-names>SA</given-names></name><name><surname>Bayraktar</surname><given-names>R</given-names></name></person-group><article-title>The effects of <italic>Nigella sativa</italic> (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family</article-title><source>Mol Biol Rep</source><volume>41</volume><issue>3</issue><year>2014</year><fpage>1703</fpage><lpage>1711</lpage><pub-id pub-id-type="doi">10.1007/s11033-014-3019-7</pub-id><pub-id pub-id-type="pmid">24413991</pub-id></element-citation></ref><ref id="bib0018"><label>18</label><element-citation publication-type="journal" id="sbref0018"><person-group person-group-type="author"><name><surname>Oyero</surname><given-names>OG</given-names></name><name><surname>Toyama</surname><given-names>M</given-names></name><name><surname>Mitsuhiro</surname><given-names>N</given-names></name></person-group><article-title>Selective inhibition of hepatitis c virus replication by alpha-zam, a <italic>Nigella sativa</italic> seed formulation</article-title><source>African J Tradit Complement Altern Med</source><volume>13</volume><issue>6</issue><year>2016</year><fpage>144</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.21010/ajtcam.v13i6.20</pub-id></element-citation></ref><ref id="bib0019"><label>19</label><element-citation publication-type="journal" id="sbref0019"><person-group person-group-type="author"><name><surname>Dorra</surname><given-names>N</given-names></name><name><surname>El-Berrawy</surname><given-names>M</given-names></name><name><surname>Sallam</surname><given-names>S</given-names></name><name><surname>Mahmoud</surname><given-names>R</given-names></name></person-group><article-title>Evaluation of Antiviral and Antioxidant Activity of Selected Herbal Extracts</article-title><source>J High Inst Public Heal</source><volume>49</volume><issue>1</issue><year>2019</year><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.21608/jhiph.2019.29464</pub-id></element-citation></ref><ref id="bib0020"><label>20</label><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Barakat</surname><given-names>EMF</given-names></name><name><surname>El Wakeel</surname><given-names>LM</given-names></name><name><surname>Hagag</surname><given-names>RS</given-names></name></person-group><article-title>Effects of <italic>Nigella sativa</italic> on outcome of hepatitis C in Egypt</article-title><source>World J Gastroenterol</source><volume>19</volume><issue>16</issue><year>2013</year><fpage>2529</fpage><lpage>2536</lpage><pub-id pub-id-type="doi">10.3748/wjg.v19.i16.2529</pub-id><pub-id pub-id-type="pmid">23674855</pub-id></element-citation></ref><ref id="bib0021"><label>21</label><element-citation publication-type="journal" id="sbref0021"><person-group person-group-type="author"><name><surname>Onifade</surname><given-names>AA</given-names></name><name><surname>Jewell</surname><given-names>AP</given-names></name><name><surname>Adedeji</surname><given-names>WA</given-names></name></person-group><article-title><italic>Nigella sativa</italic> concoction induced sustained seroreversion in HIV patient</article-title><source>Afr J Tradit Complement Altern Med</source><volume>10</volume><issue>5</issue><year>2013</year><fpage>332</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">24311845</pub-id></element-citation></ref><ref id="bib0022"><label>22</label><element-citation publication-type="journal" id="sbref0022"><person-group person-group-type="author"><name><surname>Onifade</surname><given-names>AA</given-names></name><name><surname>Jewell</surname><given-names>AP</given-names></name><name><surname>Ajadi</surname><given-names>TA</given-names></name><name><surname>Rahamon</surname><given-names>SK</given-names></name><name><surname>Ogunrin</surname><given-names>OO</given-names></name></person-group><article-title>Effectiveness of a herbal remedy in six HIV patients in Nigeria</article-title><source>J Herb Med</source><volume>3</volume><issue>3</issue><year>2013</year><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.hermed.2013.04.006</pub-id></element-citation></ref><ref id="bib0023"><label>23</label><element-citation publication-type="journal" id="sbref0023"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>JD</given-names></name><name><surname>Tatonetti</surname><given-names>NP.</given-names></name></person-group><article-title>Informatics and computational methods in natural product drug discovery: A review and perspectives</article-title><source>Front Genet</source><volume>10</volume><issue>APR</issue><year>2019</year><fpage>368</fpage><pub-id pub-id-type="doi">10.3389/fgene.2019.00368</pub-id><pub-id pub-id-type="pmid">31114606</pub-id></element-citation></ref><ref id="bib0024"><label>24</label><mixed-citation publication-type="other" id="sbref0024">Bouchentouf S, Noureddine M.Identification of Compounds from Nigella Sativa as New Potential Inhibitors of 2019 Novel Coronasvirus (COVID-19): Molecular Docking Study Elucidation of neurodegenerative pathologies processes by molecular modeling View project Molecular operating enviro. ChemRxiv. doi:<pub-id pub-id-type="doi">10.26434/chemrxiv.12055716.v1</pub-id>.</mixed-citation></ref><ref id="bib0025"><label>25</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Sekiou</surname><given-names>O</given-names></name><name><surname>Ismail</surname><given-names>B</given-names></name><name><surname>Zihad</surname><given-names>B</given-names></name><name><surname>Abdelhak</surname><given-names>D</given-names></name></person-group><article-title>In-Silico Identification of Potent Inhibitors of COVID-19 Main Protease (Mpro) and Angiotensin Converting Enzyme 2 (ACE2) from Natural Products: Quercetin, Hispidulin, and Cirsimaritin Exhibited Better Potential Inhibition than Hydroxy-Chloroquine Against</article-title><source>chemRxiv</source><year>April 2020</year><pub-id pub-id-type="doi">10.26434/chemrxiv.12181404.v1</pub-id></element-citation></ref><ref id="bib0026"><label>26</label><element-citation publication-type="journal" id="sbref0026"><person-group person-group-type="author"><name><surname>Elfiky</surname><given-names>AA.</given-names></name></person-group><article-title>Natural products may interfere with SARS-CoV-2 attachment to the host cell</article-title><source>J Biomol Struct Dyn</source><year>April 2020</year><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1761881</pub-id></element-citation></ref><ref id="bib0027"><label>27</label><element-citation publication-type="journal" id="sbref0027"><person-group person-group-type="author"><name><surname>Sampangi-ramaiah</surname><given-names>MH</given-names></name><name><surname>Vishwakarma</surname><given-names>R</given-names></name><name><surname>Shaanker</surname><given-names>RU</given-names></name></person-group><article-title>Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease</article-title><source>Curr Sci</source><volume>118</volume><issue>7</issue><year>2020</year><fpage>1087</fpage><lpage>1092</lpage><ext-link ext-link-type="uri" xlink:href="http://sts.bioe.uic.edu/castp/index.html?3igg" id="interref0005">http://sts.bioe.uic.edu/castp/index.html?3igg</ext-link><comment>Accessed May 3, 2020</comment></element-citation></ref><ref id="bib0028"><label>28</label><element-citation publication-type="journal" id="sbref0028"><person-group person-group-type="author"><name><surname>Rajapaksa</surname><given-names>RMH</given-names></name><name><surname>Perera</surname><given-names>BT</given-names></name><name><surname>Nisansala</surname><given-names>MJ</given-names></name><name><surname>Perera</surname><given-names>WPRT</given-names></name><name><surname>Dissanayake</surname><given-names>KGC</given-names></name></person-group><article-title>POTENTIAL OF INHIBITING THE RECEPTOR BINDING MECHANISM OF SARS- COV-2 USING PHYTOCHEMICAL EXTRACTS OF MEDICINAL HERB; MOLECULER DOCKING STUDY</article-title><source>Glob J Eng Sci Res Manag</source><volume>7</volume><issue>4</issue><year>2020</year><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.5281/zenodo.3766184</pub-id></element-citation></ref><ref id="bib0029"><label>29</label><element-citation publication-type="journal" id="sbref0029"><person-group person-group-type="author"><name><surname>da</surname><given-names>Silva JKR</given-names></name><name><surname>PLB</surname><given-names>Figueiredo</given-names></name><name><surname>Byler</surname><given-names>KG</given-names></name><name><surname>Setzer</surname><given-names>WN</given-names></name></person-group><article-title>Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS&#x02212;CoV&#x02212;2 Infection: An In&#x02212;Silico Investigation</article-title><source>Int J Mol Sci</source><volume>21</volume><issue>10</issue><year>2020</year><fpage>3426</fpage><pub-id pub-id-type="doi">10.3390/ijms21103426</pub-id></element-citation></ref><ref id="bib0030"><label>30</label><mixed-citation publication-type="other" id="sbref0030">Maiti S, Banerjee A, Nazmeen A, Kanwar M, Das S. Active-site Molecular docking of Nigellidine to nucleocapsid / Nsp2 / Nsp3 / M Pro of COVID-19 and to human IL1R and TNFR1 / 2 may stop viral- growth / cytokine-flood , and the drug source <italic>Nigella sativa</italic> ( black cumin ) seeds show potent antioxidant role. Research Square. doi:<pub-id pub-id-type="doi">10.21203/rs.3.rs-26464/v1</pub-id>.</mixed-citation></ref></ref-list><ack id="ack0001"><title>Acknowledgments</title><p>All authors contributed equally in the literature search, study design, data collection, data interpretation, and writing.</p><sec id="sec0004s"><title>Declaration of Competing Interest</title><p id="para0020">None.</p></sec></ack></back></article>